The Rostec Group of Companies has created the first pilot batch of "Mobivent Oxi" ventilators. They are undergoing registration with Roszdravnadzor. This was reported by the state corporation's press service.
The developers plan to fine-tune the technology of large-scale production of equipment. A number of additional improvements are also planned.
"Mobivent Oxi" can be used in the treatment of children and adults with chronic pulmonary and cardiac diseases, when insufficient blood oxygen saturation is observed. The equipment is equipped with a function for transmitting data to the information network of a medical institution.
The new devices were presented at the "Bioprom" forum.
Earlierwww1.ru reported that Rostecpresented the first domestic immunoglobulin "BioGam".
Read materials on the topic:
Rostec has developed new components for Russian cosmetics, shampoos and ointments
Without surgical intervention: Rostec has developed an apparatus for the treatment of kidney stones
